Introduction: Venous thromboembolism is the second leading cause of death in people with cancer. This risk increases in people undergoing chemotherapy.
Marcelino, Ana Isabel Robalo Lopes +4 more
core +1 more source
Cost-Benefit Limitations of Extended, Outpatient Venous Thromboembolism Prophylaxis Following Surgery for Crohn's Disease. [PDF]
Dis Colon Rectum, 2019 Leeds IL +4 more
europepmc +1 more source
Información para Pacientes con Enfermedades Vasculares: Una guía para pacientes recién diagnosticados con trombosis venosa profunda y/o tromboembolismo pulmonar. [PDF]
Vasc Med, 2023 Barnett B +3 more
europepmc +1 more source
New anticoagulants for the treatment of venous thromboembolism. [PDF]
J Bras Pneumol, 2016 Fernandes CJ +5 more
europepmc +1 more source
Adequacy of venous thromboembolism risk stratification and prophylaxis in a tertiary university hospital. [PDF]
J Vasc Bras, 2023 Ramalli EL +3 more
europepmc +1 more source
Serum Levels of sCD40L, CCL3, and NT-proBNP in Elderly Patients Admitted to the Hospital with HF. [PDF]
Arq Bras CardiolHorta MDGC, Borin MC.
europepmc +1 more source
Prevenção do tromboembolismo venoso no trauma [PDF]
Revista da Associação Médica Brasileira, 2002 openaire +2 more sources
Venous thromboembolism prophylaxis after total knee arthroplasty (TKA): aspirin vs. rivaroxaban. [PDF]
Rev Bras Ortop, 2018 Colleoni JL +5 more
europepmc +1 more source
Estetrol and its implications for contraception, venous thromboembolism, and breast cancer: an integrative review. [PDF]
J Vasc BrasMarques MA +4 more
europepmc +1 more source